Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Post by Jordan1159on Apr 11, 2022 3:12pm
308 Views
Post# 34594609

Cardiol will run north in time no doubt

Cardiol will run north in time no doubtCardiol Therapeutics shares could go up in value very quickly here! With the world under a Covid umbrella that doesn't appear to folded up by mother nature anytime soon, Cardiol is in a position to be a game changer company that potentially could be bought out by a big pharma company - this wont surprise me. Cardiols CEO's last company had a 1 billion market cap!!!!!!! Very intelligent man, Dave Elsley, and is one of the main reasons im here - again!! Patients could be rewarded - get it? Check into them and draw your own conclusions.
<< Previous
Bullboard Posts
Next >>